Pharmakon Advisors
North America, New York, United States, New York
Description
Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.
Investor Profile
Pharmakon Advisors has backed more than 18 startups, with 2 new investments in the last 12 months alone. The firm has led 11 rounds, about 61% of its total and boasts 15 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Debt, Series A, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Norway.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 2 rounds in the past year.
Stage Focus
- Post Ipo Debt (83%)
- Series A (6%)
- Post Ipo Equity (6%)
- Debt Financing (6%)
Country Focus
- United States (94%)
- Norway (6%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Biopharma
- Life Science
- Oncology
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
